CORREVIO PHARMA CORP's ticker is CORV and the CUSIP is 22026V105. A total of 40 filers reported holding CORREVIO PHARMA CORP in Q3 2019. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $33,000 | – | 16,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 4,325,000 | $8,650,000 | 42.79% |
| Tamarack Advisers, LP | 4,500,000 | $9,000,000 | 2.34% |
| Stonepine Capital Management, LLC | 509,356 | $1,019,000 | 0.99% |
| CLOUGH CAPITAL PARTNERS L P | 2,057,124 | $4,114,000 | 0.34% |
| Worth Venture Partners, LLC | 101,364 | $203,000 | 0.12% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 349,148 | $698,000 | 0.10% |
| Rock Springs Capital Management LP | 1,200,000 | $2,400,000 | 0.10% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 4,876,455 | $9,753,000 | 0.08% |
| ARS Investment Partners, LLC | 215,718 | $431,000 | 0.08% |
| Perceptive Advisors | 1,000,000 | $2,000,000 | 0.05% |